AtriCure, Inc.’s $88 Million Common Stock Offering

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an $88 million SEC-registered follow-on offering of 2,875,000 shares of common stock of AtriCure, Inc.

The common stock is listed on the NASDAQ Global Market under the symbol “ATRC.”

J.P. Morgan and Piper Jaffray acted as Joint Book-Running Managers ont the offering.

Based in Mason, Ohio, AtriCure, Inc. is a provider of innovative technologies for the treatment of atrial fibrillation and related conditions.

The Davis Polk corporate team included partner Alan F. Denenberg (Picture), counsel Jason Bassetti and associates Josephine Chen and Katherine Schloss Ackerman. The tax team included partner Rachel D. Kleinberg and associate M. Brett Cameron. The intellectual property and technology team included partner Pritesh P. Shah and associate Yifu Chen.

Involved fees earner: Katherine Schloss Ackerman – Davis Polk & Wardwell; Josephine Chen – Davis Polk & Wardwell; Jason Bassetti – Davis Polk & Wardwell; Alan Denenberg – Davis Polk & Wardwell; Rachel Kleinberg – Davis Polk & Wardwell; Brett Cameron – Davis Polk & Wardwell; Pritesh P. Shah – Davis Polk & Wardwell; Yifu Chen – Davis Polk & Wardwell;

Law Firms: Davis Polk & Wardwell;

Clients: JP Morgan; Piper Jaffray & Co;

Author: Ambrogio Visconti